A Phase Ib Study of AZD5462 on Top of Dapagliflozin in Participants With Heart Failure and Moderate Renal Impairment

NCT06639087 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

8

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor Decision

Conditions

Renal Impairment
Heart Failure

Interventions

DRUG: AZD5462
DRUG: Dapagliflozin
OTHER: Placebo

Sponsor

AstraZeneca

Collaborators

[object Object]